# FDA Agrees to Review Phentolamine for Presbyopia

Page: https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/fda-agrees-to-review-phentolamine-for-presbyopia
Text version: https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/fda-agrees-to-review-phentolamine-for-presbyopia.md
Podcast: [Eyewire News: The Podcast](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536)
Published: 2026-03-04T21:07:00+00:00
Episode link: https://traffic.megaphone.fm/BMCL2873046322.mp3
Audio file: https://traffic.megaphone.fm/BMCL2873046322.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/fda-agrees-to-review-phentolamine-for-presbyopia
Duration seconds: 691

## Resource

The FDA agrees to review a presbyopia drop designed to modulate pupil dynamics; a new endocapsular device receives clearance in Europe; and Rayner makes an acquisition to expands its cataract surgery portfolio. Learn more about your ad choices. Visit megaphone.fm/adchoices

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/fda-agrees-to-review-phentolamine-for-presbyopia/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/fda-agrees-to-review-phentolamine-for-presbyopia.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.